Interbody Fusion System
FlareHawk9™ is a multidirectional expandable lumbar fusion device, featuring our innovative Adaptive Geometry™, that can be inserted at a low profile of 7mm or 9mm tall by 9mm wide before expanding up to 14mm tall and 14mm wide.
FlareHawk Retrospective Data
Bidirectional Expandable Technology for Transforaminal or Posterior Lumbar Interbody Fusion: A Retrospective Analysis of Safety and Performance
*Cage subsidence defined as an overlap between the vertebral endplates and the device exceeding 25% of the device height. **Device migration was defined as displacement of the device relative to the position within intra-operative or immediate post-operative images. Analysis of that case revealed that the patient went on to fuse and did not require reoperation.
Domagoj Coric, Raphael R. Roybal, Mark Grubb, Vincent Rossi, Alex K. Yu, Isaac R. Swink, Jason Long, Boyle C. Cheng and Jason A. Inzana in International Journal of Spine Surgery October 2020, 7123; DOI: https://doi.org/10.14444/7123
MINIMAL INSERTION PROFILE
FlareHawk’s insertion profile of 7-9mm H x 9mm W is smaller than several other commercially available expandable interbodies.
Adaptive Geometry technology delivers expansion in width (starting at 9mm, expanding to 14mm), height (starting at 7 or 9mm, expanding up to 14mm), and lordosis (0°, 6°, 9° and 15°).
SUBSTANTIAL GRAFT DELIVERY
Open architecture allows for substantial graft delivery post implantation into and through the implant into the surrounding disc space. Graft volume is only restricted by the volume of disc removed.
INDICATIONS FOR USE/INTENDED USE
The FlareHawk® Interbody Fusion System is indicated for spinal intervertebral body fusion with autogenous bone graft and/or allogeneic bone graft composed of cancellous and/or corticocancellous bone in skeletally mature individuals with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1, following discectomy.
DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should have at least six (6) months of non-operative treatment. Additionally, these patients may have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). FlareHawk® system spacers are intended to be used with supplemental fixationinstrumentation, which has been cleared for use in the lumbar spine.